B-cell activating factor receptor (BAFF-R) chimeric antigen receptor (CAR) T-cell therapy incited cytotoxic effects on both ...
Study shows that dietary antigens can suppress small intestine carcinogenesis by activating T-cells through Peyer's patches.
New Mechanistic Insights Underscore Multiple Potential Roles for Elraglusib as an Immune Modulator in the treatment of ...
Umoja Biopharma, Inc. (Umoja), a transformative immunotherapy company creating off-the-shelf treatments that aim to extend the reach and effectiveness of CAR-T cell therapies in oncology and ...
By: Milan Sheth, M.D., hematology/oncology, MemorialCare Todd Cancer Institute at Long Beach Medical Center MemorialCare is ...
In a recent study published in Nature Immunology, researchers investigated the direct influence of sodium (Na+) ions on the cytotoxic cluster of differentiation 8 (CD8)-expressing T cells and ...
The following is a summary of “Hematopoietic stem cell transplantation for CTLA-4 insufficiency across Europe: A European ...
Effector CD8 + T cells with cytotoxic ability are crucial for immunotherapy success. Two studies show that salt (NaCl) supplementation can enhance the effector function of CD8 + T cells and boost ...
ABT-301, a novel HDAC inhibitor, has shown promising safety and pharmacokinetic profiles in a prior Phase 1 study as a single agent. Preclinical studies indicate that ABT-301 enhances the ...